Page last updated: 2024-09-05

gm237354 and sordarin

gm237354 has been researched along with sordarin in 4 studies

Compound Research Comparison

Studies
(gm237354)
Trials
(gm237354)
Recent Studies (post-2010)
(gm237354)
Studies
(sordarin)
Trials
(sordarin)
Recent Studies (post-2010) (sordarin)
50070018

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clemons, KV; Stevens, DA1
Aviles, P; Falcoz, C; Gargallo-Viola, D; San Roman, R1
Aviles, P; Falcoz, C; Gargallo-Viola, D; Gómez De Las Heras, F; Guillén, MJ; San Roman, R1
Alía, C; Baró, T; Jiménez, T; López, O; Morera, Y; Torres-Rodríguez, JM1

Other Studies

4 other study(ies) available for gm237354 and sordarin

ArticleYear
Efficacies of sordarin derivatives GM193663, GM211676, and GM237354 in a murine model of systemic coccidioidomycosis. p6.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:7

    Topics: Animals; Antifungal Agents; Coccidioidomycosis; Disease Models, Animal; Female; Indenes; Mice; Treatment Outcome

2000
Pharmacokinetics-pharmacodynamics of a sordarin derivative (GM 237354) in a murine model of lethal candidiasis.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:9

    Topics: Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Disease Models, Animal; Indenes; Male; Mice; Microbial Sensitivity Tests; Statistics as Topic; Treatment Outcome

2000
Correlation between in vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein binding.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:10

    Topics: Animals; Antifungal Agents; Binding Sites; Blood Proteins; Candida albicans; Candidiasis; Disease Models, Animal; Indenes; Male; Mice; Microbial Sensitivity Tests; Models, Biological; Statistics as Topic; Treatment Outcome

2001
In vitro susceptibility of Cryptococcus neoformans serotypes to GM 237354 derivative of the sordarin class.
    Mycoses, 2002, Volume: 45, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Humans; Indenes; Microbial Sensitivity Tests; Serotyping

2002